Take a fresh look at your lifestyle.

AstraZeneca vaccine booster shot effective against Omicron – Oxford lab study

Investing.com - Financial Markets Worldwide

Please try another search

Stock Markets17 minutes ago (Dec 23, 2021 02:42AM ET)

AstraZeneca vaccine booster shot effective against Omicron - Oxford lab study © Reuters. FILE PHOTO: People pose with syringe with needle in front of displayed AstraZeneca logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) – A three-dose course of AstraZeneca (NASDAQ:)’s COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.

The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.

After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus’s Delta variant after two doses, the company added.

The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca.

Related Articles

Australia stocks higher at close of trade; S&P/ASX 200 up 0.31%

Australia stocks higher at close of trade; S&P/ASX 200 up 0.31% By Investing.com – Dec 23, 2021

Investing.com – Australia stocks were higher after the close on Thursday, as gains in the Gold, Utilities and Industrials sectors led shares higher. At the close in Sydney, the…

Japan stocks higher at close of trade; Nikkei 225 up 0.83%

Japan stocks higher at close of trade; Nikkei 225 up 0.83% By Investing.com – Dec 23, 2021

Investing.com – Japan stocks were higher after the close on Thursday, as gains in the Paper & Pulp, Railway & Bus and Real Estate sectors led shares higher. At the close in Tokyo,…

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More